Leading Regenerative MedicineRodman & Renshaw Global Investment ConferenceSeptember 2012 This presentation is intended to present a summary of ACT’s (“ACT”, or…

1. Advanced Cell TechnologyCorporate PresentationOctober 20101 2. This presentation is intended to present a summary of ACT’s (“ACT”, or “AdvancedCell Technology…

Slide 1Research Perspectives and the Promise of Clinical Trials for Treatment of RP and Allied Diseases: ohenetihool L Gerald J. Chader, Ph.D., M.D.hc Doheny Eye Institute…

Slide 1Present and Future Treatments for Retinal Degenerative Diseases: An Overview Gerald J. Chader Doheny Retina Institute USC Medical School Los Angeles, CA Slide 2 WHAT…

1. A Systematic Comparison ofSpectral-Domain Optical CoherenceTomography and Fundus Autofluorescencein Patients with Geographic AtrophyRamzi G. Sayegh, MD,1 Christian Simader,…

1. Ocata Therapeutics Corporate Presentation June 2015 2. Cautionary Statement Concerning Forward-Looking Statements Ocata Therapeutics Inc. (“Ocata” or “the Company”)…

1. What our eyes need most? 2. Essential nutrients for our healthy sight 3. What are the major essential vitamins & minerals for healthy eyes? Vitamin C Vitamin E Lutein…

1. Characterization of the Stiffness and Cytotoxicity of Poly(ethylene glycol) Diacrylate Hydrogels for Retinal Tissue Engineering Tyler DiStefano1, Corina White2, Dr. Ronke…

Slide 1 Advances in the Treatment of Age-Related Macular Degeneration (AMD) Michael E. Helm, PA-S Spring 2007 Advisor: Sam Powdrill, MPhil, PA-C Slide 2 What is AMD? Age-related…

Slide 1 Macular Degeneration and Diabetic Retinopathy Carmen Leyva Vicki Herrin Hampton Huddleston Stephen F. Austin State University Slide 2 What is Macular Degeneration?…